IGLL5 and prostate carcinoma: IGLL5, the main positive contributor to both nodules “A” and “B”, was correlated with tumor-infiltrating immune cells in kidney cancer [103], suggesting an interesting study to determine whether it plays a similar role in prostate cancer.